Literature DB >> 3382353

Risk factors affecting the natural history of intermittent claudication.

M S Rosenbloom1, D P Flanigan, J J Schuler, J P Meyer, J R Durham, J Eldrup-Jorgensen, T H Schwarcz.   

Abstract

To determine the prognostic significance of the level of arterial disease in claudicators, risk factors affecting the progression of intermittent claudication, including hemodynamic variables obtained from noninvasive vascular laboratory examinations, were assessed. We identified 378 patients with intermittent claudication by characteristic history and the presence of abnormal treadmill exercise examination results. Results of serial examinations were available for 195 of these patients, who had 310 claudicating limbs. Life-table analysis revealed that after eight years, 41% of these patients had progressed to critical ischemia, defined as rest pain or tissue loss, and 50% had died. Cox proportional hazards general linear regression analysis found that at a patient's first examination in the vascular laboratory, the ankle-brachial index and the decrease in ankle-brachial index after exercise were significantly associated with the subsequent development of critical ischemia. The level of disease at the initial examination in the vascular laboratory was not a significant risk factor for progression to critical ischemia and therefore should not be used as an indicator for or against operation in patients with intermittent claudication.

Entities:  

Mesh:

Year:  1988        PMID: 3382353     DOI: 10.1001/archsurg.1988.01400310081013

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  5 in total

1.  Noninvasive vascular diagnosis.

Authors:  L M Taylor
Journal:  West J Med       Date:  1989-08

2.  Medical cost savings from pentoxifylline therapy in chronic occlusive arterial disease.

Authors:  K Neels; S Finkelstein; C Douglass
Journal:  Pharmacoeconomics       Date:  1994-02       Impact factor: 4.981

Review 3.  The prognosis of non-critical limb ischaemia: a systematic review of population-based evidence.

Authors:  J D Hooi; H E Stoffers; J A Knottnerus; J W van Ree
Journal:  Br J Gen Pract       Date:  1999-01       Impact factor: 5.386

4.  Extensive skeletal muscle cell mitochondriopathy distinguishes critical limb ischemia patients from claudicants.

Authors:  Terence E Ryan; Dean J Yamaguchi; Cameron A Schmidt; Tonya N Zeczycki; Saame Raza Shaikh; Patricia Brophy; Thomas D Green; Michael D Tarpey; Reema Karnekar; Emma J Goldberg; Genevieve C Sparagna; Maria J Torres; Brian H Annex; P Darrell Neufer; Espen E Spangenburg; Joseph M McClung
Journal:  JCI Insight       Date:  2018-11-02

Review 5.  [Recommended interventions for the treatment of peripheral artery disease : Keep the patients moving].

Authors:  H Krankenberg
Journal:  Internist (Berl)       Date:  2019-12       Impact factor: 0.743

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.